Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.04%
#2 Ocean Protocol Ocean Protocol +17.97%
#3 KUB Coin KUB Coin +16.96%
#4 Geodnet Geodnet +13.43%
#5 Audiera Audiera +12.11%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +8.18%
#7 DexNet DexNet +7.78%
#8 Cysic Cysic +7.16%
#9 Ontology Gas Ontology Gas +6.91%
#10 Arowana Arowana +6.80%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
Pozycja w akcjach #32245
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
Cena akcji
$4.65
Ostatnia synchronizacja: 2024-07-24
Kapitalizacja rynkowa
$10.63M
Zmiana (1 dzień)
6.66%
Zmiana (1 rok)
0.00%
Kraj
AU
Handel Medlab Clinical Limited (MDC)

Kategoria

Healthcare
Historia ceny akcji dla Medlab Clinical Limited (MDC)
Najwyższa cena zamknięcia: $4.65 dnia 2024-07-01

Najniższa cena zamknięcia: $20.06 dnia 2015-07-01
Historia cen akcji firmy Medlab Clinical Limited od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 5.52%
2023 -8.38%
2022 -69.42%
2021 -45.35%
2020 -15.13%
2019 -18.05%
2018 -52.21%
2017 -8.72%
2016 360.38%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.82 -36.53%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.43%
KR